The novel therapy of the medication represents a significant advance in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide384744.madmouseblog.com/22766740/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment